Akebia Therapeutics, Inc. Made Headway

Fri 22 Nov 19 at 05:30 PM
Akebia Therapeutics, Inc. Made Headway

Akebia Therapeutics, Inc. (AKBA:NASDAQ) rocketted today at $4.21, representing a gain of 21.7%. The stock featured on our News Catalysts scanner on Thu 21 Nov 19 at 08:52 AM. From Fri 01 Nov 19, the stock recorded 50.00% Up Days and 46.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Akebia Therapeutics, Inc. (AKBA:NASDAQ)

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.